The company does not provide detailed information ... announced that the U.S. Food and Drug Administration (FDA) has approved an update for the label for Qelbree (viloxazine extended-release ...
and Novo Nordisk can now claim to have the first medication in this class approved for chronic kidney disease. The FDA has expanded the label of Ozempic, approving the Novo Nordisk product for ...
The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition ...
Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...
For the first time in two decades, the FDA has approved a new class of non-opioid ... according to the FDA. Suzetrigine is not considered addictive. Unlike opioids, which carry a high potential ...
(Reuters) -The U.S. FDA has approved ... the FDA had approved the use of Wegovy for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The Food and Drug Administration (FDA) approved Johnson & Johnson's ... saying it wasn’t "negative news." However, off-label use of the drug has "skyrocketed" in recent years, "despite limited ...